Pharmaceutical

A federal register notice confirmed dates for the anticipated advisory meeting, which will follow an FDA decision to narrow COVID boosters' approval a...

The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya Therapeutics for COYA 302, enabling the...

Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001, a radiopharmaceutical intended...

The deal will bring together Waltz's proprietary drug marketplaces and direct-to-payer model with Eversana's global pharmaceutical commercialization p...

The therapy offers a more accessible option to patients with hematological malignancies (blood cancers) who don't have access to suitable donor cells...

Phreesia is bringing Sesame Street to the doctor’s office. The patient activation company has partnered with the nonprofit behind the TV show to work...

For the third year in a row, Cleveland Diagnostics is commemorating September’s Prostate Cancer Awareness Month with its “A PSA on PSA” campaign that...

A new report from MassBio suggests the state isn’t immune to the funding slowdowns and policy shifts that have put pressure on the industry over the p...

Amylyx’s withdrawn-from-market Relyvrio has failed to make an impact on primary or secondary endpoints in a rare neurodegenerative disease, prompting...

Eli Lilly’s Verzenio has proven its ability to prolong the lives of patients with HR-positive, HER2-negative, node-positive high-risk early breast can...